Conference Coverage

Targeting inactivity, mood, and cognition could be key to reducing OA mortality


 

REPORTING FROM OARSI 2018

– Osteoarthritis is associated with an increased risk in mortality, but three factors – inactivity, low mood, and cognitive ability – could be important targets to reduce this risk, according to the results of a study presented at the World Congress on Osteoarthritis.

“There’s recently been increasing interest in whether osteoarthritis (OA) is associated with mortality as the literature has failed to find a consistent link,” said Simran Parmar, a third-year medical student at Keele University, Newcastle-Under-Lyme, U.K.

Simran Parmar, a third-year medical student at Keele University, Newcastle-Under-Lyme, England Sara Freeman/MDedge News

Simran Parmar

The first systematic review conducted by Marc C. Hochberg 10 years ago (Clin Exp Rheumatol. 2008;26:S120–4) showed “moderate evidence” of increased mortality caused by OA, compared with the general population, Mr. Parmar elaborated at the congress, which is sponsored by the Osteoarthritis Research Society International.

Three years later, data from another study (BMJ. 2011;342:d1165) suggested an increased risk, with standardized mortality ratios calculated to be 1.55 for all-cause mortality and 1.71 for cardiovascular-specific mortality when comparing those with OA to those without OA in the general population.

However, more recent meta-analyses, performed in 2016, have failed to show a relationship between mortality and OA (Semin Arthritis Rheum. 2016;46[2]:160–7; Sci Rep. 2016;6:24393).

“This could be because of heterogeneity among the studies,” Mr. Parmar reasoned, adding that there was still an unclear relationship between OA and mortality.

So the aim of the current study was not only to take another look at the association to determine its strength but also to see what factors might be mediating the association in order to perhaps explain why OA might be associated with an increased risk of death.

Pages

Recommended Reading

Esketamine nasal spray brings fast relief of depressive symptoms
MDedge Family Medicine
Change in approach advised for treatment-resistant depression
MDedge Family Medicine
Focus on early maladaptive schemas can reduce PTSD burden
MDedge Family Medicine
Suicide prevention, NRA team up for safer gun storage
MDedge Family Medicine
Fetal exposure to depression: How does ‘dose’ figure in?
MDedge Family Medicine
Suicide on the minds of many Utah teens
MDedge Family Medicine
Ketamine formulation study is ‘groundbreaking’
MDedge Family Medicine
Hidradenitis suppurativa packs mighty QOL impact
MDedge Family Medicine
Anticholinergics’ link to dementia calls for vigilance in elderly
MDedge Family Medicine
VIDEO: National suicide hotline could result from pending U.S. law
MDedge Family Medicine